GlassScriptPhysician profile
Paul K White
NPI 1225355993
$7,893.35
in general payments reported to CMS, 2019-2025
24 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,415 · 2020: $1,670 · 2021: $1,573 · 2022: $517 · 2023: $1,328 · 2024: $1,093 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,719.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,287.01 | 2019-2024 | Proclaim, Eterna |
| Medtronic, INC. | $1,087.90 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $821.64 | 2019-2024 | Relistor |
| Boston Scientific Corporation | $671.99 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $341.76 | 2019-2020 | |
| Nevro Corp. | $261.00 | 2019-2023 | Senza |
| Biotronik Nro, INC. | $249.50 | 2024-2025 | Prospera |
| Collegium Pharmaceutical, INC. | $220.11 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $185.79 | 2019 | |
| Averitas Pharma INC. | $128.35 | 2023-2024 | Qutenza |
| Globus Medical, INC. | $124.60 | 2024 | Xlif, Alif Instruments (Universal), Citadel |
| Relievant Medsystems, INC. | $115.28 | 2023 | Intracept |
| Vertiflex, INC. | $101.69 | 2019 | |
| Redhill Biopharma INC. | $68.08 | 2021 | |
| Trevena, INC. | $39.94 | 2023 | Olinvyk |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $33.54 | 2019-2021 | |
| Ermi LLC | $29.15 | 2023 | |
| Biodelivery Sciences International, INC. | $29.11 | 2019-2021 | |
| Grt US Holding, INC. | $19.16 | 2022 | |
| Mdd US Operations, LLC | $18.40 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.82 | 2020 | |
| Vertical Pharmaceuticals, LLC | $16.81 | 2019 | |
| Horizon Therapeutics Plc | $14.14 | 2019 | |
| Pfizer INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.